Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kaken Pharmaceutical

Clinical trials sponsored by Kaken Pharmaceutical, explained in plain language.

Kaken Pharmaceutical 4521 TOKYO

A Japanese pharmaceutical company focused on dermatology and anti-inflammatory drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 3

New pill could shrink abnormal vessels in rare childhood disorders

Disease control Recruiting now

This Phase 3 trial tests an oral drug called KP-001 in 150 people aged 2 and older with venous malformations, lymphatic malformations, or KTS/CLOVES syndrome. Participants receive either KP-001 or a placebo for 24 weeks, then everyone gets the drug for another 28 weeks. The goal …

Phase: PHASE3 • Sponsor: Kaken Pharmaceutical • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC